Yi Huang, Yuwei Zhong, Hongfei Lu, Kai Jin, Yue Zhang, Lin Yu, Jinliang Liu, Xiaohui Zhu, Yihan Wu
{"title":"In Situ Construction of Upconverting Nano-Bacteria Biohybrids via Biomimetic Mineralization for Synergistic Antitumor Phototherapy.","authors":"Yi Huang, Yuwei Zhong, Hongfei Lu, Kai Jin, Yue Zhang, Lin Yu, Jinliang Liu, Xiaohui Zhu, Yihan Wu","doi":"10.1021/acsami.5c17095","DOIUrl":null,"url":null,"abstract":"<p><p>Nano-bacteria biohybrids, which combine the advantages of nanomaterials and bacterial cells, have emerged as innovative platforms for cancer treatment. Integrated with optical nanomaterials, these biohybrids enable effective phototherapy. To overcome the challenge of limited tissue penetration by visible light in phototherapy, upconversion nanoparticles can be used to convert near-infrared (NIR) light into visible light, enabling the treatment of deep-seated tumors. In this study, we present a rapid method to fabricate upconversion nanoparticle-bacteria biohybrids (<i>E. coli</i>@BiF<sub>3</sub>:Yb/Er) via biomimetic mineralization under biocompatible conditions within minutes. Additionally, palladium nanoparticles are co-mineralized, enabling the biohybrids to perform both photodynamic and photothermal therapies under NIR light. When applied to mouse models of melanoma and cervical cancer, these biohybrids target the tumor sites efficiently without causing systemic toxicity. Upon excitation with 980 and 808 nm NIR light, these biohybrids effectively suppressed tumor growth, highlighting their potential as a multifunctional therapeutic strategy for cancer treatment.</p>","PeriodicalId":5,"journal":{"name":"ACS Applied Materials & Interfaces","volume":" ","pages":""},"PeriodicalIF":8.2000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Materials & Interfaces","FirstCategoryId":"88","ListUrlMain":"https://doi.org/10.1021/acsami.5c17095","RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MATERIALS SCIENCE, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Nano-bacteria biohybrids, which combine the advantages of nanomaterials and bacterial cells, have emerged as innovative platforms for cancer treatment. Integrated with optical nanomaterials, these biohybrids enable effective phototherapy. To overcome the challenge of limited tissue penetration by visible light in phototherapy, upconversion nanoparticles can be used to convert near-infrared (NIR) light into visible light, enabling the treatment of deep-seated tumors. In this study, we present a rapid method to fabricate upconversion nanoparticle-bacteria biohybrids (E. coli@BiF3:Yb/Er) via biomimetic mineralization under biocompatible conditions within minutes. Additionally, palladium nanoparticles are co-mineralized, enabling the biohybrids to perform both photodynamic and photothermal therapies under NIR light. When applied to mouse models of melanoma and cervical cancer, these biohybrids target the tumor sites efficiently without causing systemic toxicity. Upon excitation with 980 and 808 nm NIR light, these biohybrids effectively suppressed tumor growth, highlighting their potential as a multifunctional therapeutic strategy for cancer treatment.
期刊介绍:
ACS Applied Materials & Interfaces is a leading interdisciplinary journal that brings together chemists, engineers, physicists, and biologists to explore the development and utilization of newly-discovered materials and interfacial processes for specific applications. Our journal has experienced remarkable growth since its establishment in 2009, both in terms of the number of articles published and the impact of the research showcased. We are proud to foster a truly global community, with the majority of published articles originating from outside the United States, reflecting the rapid growth of applied research worldwide.